chr10-62670472-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The XM_047426120.1(LOC124902436):c.*171C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00745 in 571,208 control chromosomes in the GnomAD database, including 160 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.021 ( 134 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 26 hom. )
Consequence
LOC124902436
XM_047426120.1 3_prime_UTR
XM_047426120.1 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.305
Genes affected
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 10-62670472-C-A is Benign according to our data. Variant chr10-62670472-C-A is described in ClinVar as [Benign]. Clinvar id is 1225274.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0689 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LOC124902436 | XM_047426120.1 | c.*171C>A | 3_prime_UTR_variant | 6/6 | XP_047282076.1 | |||
LOC124902436 | XM_047426118.1 | c.*171C>A | 3_prime_UTR_variant | 6/6 | XP_047282074.1 | |||
LOC124902436 | XM_047426121.1 | c.*171C>A | 3_prime_UTR_variant | 6/6 | XP_047282077.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LINC02929 | ENST00000395251.5 | n.1156C>A | non_coding_transcript_exon_variant | 7/7 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0207 AC: 3155AN: 152068Hom.: 133 Cov.: 32
GnomAD3 genomes
AF:
AC:
3155
AN:
152068
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00259 AC: 1086AN: 419022Hom.: 26 Cov.: 4 AF XY: 0.00209 AC XY: 465AN XY: 222634
GnomAD4 exome
AF:
AC:
1086
AN:
419022
Hom.:
Cov.:
4
AF XY:
AC XY:
465
AN XY:
222634
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0208 AC: 3168AN: 152186Hom.: 134 Cov.: 32 AF XY: 0.0197 AC XY: 1467AN XY: 74406
GnomAD4 genome
AF:
AC:
3168
AN:
152186
Hom.:
Cov.:
32
AF XY:
AC XY:
1467
AN XY:
74406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
18
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 22, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at